Hanwha Chemical Sells Biosimilar License To Merck For $720 Million
June 12, 2011 at 21:07 PM EDT
SEOUL -(Dow Jones)- South Korea's Hanwha Chemical Corp. (009830.SE) said Monday it has agreed to sell its biosimilar license to a subsidiary of Merck & Co Inc. (MRK) for about $720 million.
